Ligand-based modelling followed by synthetic exploration unveil novel glycogen phosphorylase inhibitory leads
2011
Habash, Maha | Taha, Mutasem O.
Glycogen phosphorylase (GP) is a valid anti-diabetic target. Accordingly, we applied a drug discovery workflow to unveil novel inhibitory GP leads via combining pharmacophore modeling, QSAR analysis and in silico screening, followed by synthetic exploration of active hits. Virtual screening identified six low micromolar inhibitory leads from the National Cancer Institute (NCI) list of compounds. The most potent hits exhibited anti-GP IC₅₀ values of 3.2 and 4.1μM. Synthetic exploration of hit 59 (IC₅₀=4.1μM) yielded 25 lead inhibitors with the best illustrating IC₅₀ of 3.0μM. Interestingly, we prepared several novel mixed oxalyl amide anti-GP leads employing new chemical reaction involving succinic acid-based adducts.
Show more [+] Less [-]AGROVOC Keywords
Bibliographic information
This bibliographic record has been provided by National Agricultural Library